Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Individual Preparation Administrations to Raise Your Wellness Process - 2Which Switch Game Do You Suggest? Share Your Decision
- 3Antivirus Programming for Exhaustive Security
- 4Japan deploys the military to counter a surge in bear attacks
- 5Step by step instructions to Guarantee Your Fender bender Legal counselor has Areas of strength for a Record
- Inconceivable Spots To Stargaze All over The Planet
- Man triggers smoke bomb during failed crypto robbery
- Tehran defends ship seizure as a legal action, but tensions continue in the Gulf
- Find Wonderful Stream Voyage Objections On the planet
- The most effective method to Pick the Right Teeth Substitution Choice for You
- Takeda's AI-crafted psoriasis pill succeeds in late-stage studies
- The most effective method to Really Adjust Hypothesis and Practice in Your Brain science Studies
- Brazilian cardinal orders a popular Catholic priest to go offline following right-wing attacks
- 6 Shades Brands For Seniors
